POLN
Basic information
Region (hg38): 4:2071918-2242121
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (195 variants)
- not_provided (8 variants)
- Prostate_cancer (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLN gene is commonly pathogenic or not. These statistics are base on transcript: NM_000181808.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 100 | 14 | 116 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 100 | 15 | 3 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| POLN | protein_coding | protein_coding | ENST00000511885 | 24 | 170204 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 9.49e-41 | 8.74e-8 | 125121 | 0 | 627 | 125748 | 0.00250 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.0475 | 481 | 478 | 1.01 | 0.0000248 | 5872 |
| Missense in Polyphen | 116 | 127.67 | 0.90858 | 1698 | ||
| Synonymous | 0.846 | 168 | 183 | 0.920 | 0.0000102 | 1711 |
| Loss of Function | -0.927 | 57 | 49.9 | 1.14 | 0.00000244 | 608 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0112 | 0.0110 |
| Ashkenazi Jewish | 0.00357 | 0.00348 |
| East Asian | 0.00565 | 0.00562 |
| Finnish | 0.00173 | 0.00171 |
| European (Non-Finnish) | 0.00177 | 0.00176 |
| Middle Eastern | 0.00565 | 0.00562 |
| South Asian | 0.00106 | 0.00105 |
| Other | 0.00213 | 0.00212 |
dbNSFP
Source:
- Function
- FUNCTION: DNA polymerase with very low fidelity that catalyzes considerable misincorporation by inserting dTTP opposite a G template, and dGTP opposite a T template (PubMed:16787914, PubMed:17118716). Is the least accurate of the DNA polymerase A family (i.e. POLG, POLN and POLQ) (PubMed:17118716). Can perform accurate translesion DNA synthesis (TLS) past a 5S-thymine glycol. Can perform efficient strand displacement past a nick or a gap and gives rise to an amount of product similar to that on non-damaged template. Has no exonuclease activity (PubMed:16787914). Error- prone DNA polymerase that preferentially misincorporates dT regardless of template sequence (PubMed:25775266). May play a role in TLS during interstrand cross-link (ICL) repair (PubMed:19908865). May be involved in TLS when genomic replication is blocked by extremely large major groove DNA lesions. May function in the bypass of some DNA-protein and DNA-DNA cross- links. May have a role in cellular tolerance to DNA cross-linking agents (PubMed:20102227). Involved in the repair of DNA cross- links and double-strand break (DSB) resistance. Participates in FANCD2-mediated repair. Forms a complex with HELQ helicase that participates in homologous recombination (HR) repair and is essential for cellular protection against DNA cross-links (PubMed:19995904). {ECO:0000269|PubMed:16787914, ECO:0000269|PubMed:17118716, ECO:0000269|PubMed:19908865, ECO:0000269|PubMed:19995904, ECO:0000269|PubMed:20102227, ECO:0000269|PubMed:25775266}.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);Fanconi Anemia Pathway;DNA Repair;Purine metabolism;Pyrimidine metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.543
- rvis_EVS
- 0.65
- rvis_percentile_EVS
- 84.18
Haploinsufficiency Scores
- pHI
- 0.0656
- hipred
- N
- hipred_score
- 0.457
- ghis
- 0.503
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.542
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Poln
- Phenotype
- cellular phenotype; normal phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- double-strand break repair via homologous recombination;DNA-dependent DNA replication;translesion synthesis;interstrand cross-link repair
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytoplasm
- Molecular function
- DNA binding;DNA-directed DNA polymerase activity;protein binding;cyclin binding